Aphria Inc.
Aphria supplies 100% greenhouse-grown, pharma-grade medical cannabis. Cannabis capsules, oral solutions, concentrate syringes, cannabinoid vaporizers, and cannabis oils are available for medicinal use. Their main facility is based in Leamington, Canada and is responsible for the cultivation, harvesting, drying, and blending of their product ranges. Their secondary site is located in Florida, USA.
Aphria supplies 100% greenhouse-grown, pharma-grade medical cannabis. Cannabis capsules, oral solutions, concentrate syringes, cannabinoid vaporizers, and cannabis oils are available for medicinal use. Their main facility is based in Leamington, Canada and is responsible for the cultivation, harvesting, drying, and blending of their product ranges. Their secondary site is located in Florida, USA.
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
APHA |
$166,297,028
|
19.89% |
$12.4312
|
| APHA |
Total volume
$669,726,237
|
80.11% |
Stock price
$12.4300
|
